Premier Anti-Aging to Propose Stock Options for Directors; Shares Down 12%
Premier Anti-Aging (TYO:4934) will propose stock options for its directors at the 15th ordinary general meeting of shareholders on Oct. 29, according to a Thursday filing on the Tokyo Stock Exchange.
The plan includes allocating up to 40 million yen annually in stock acquisition rights, separate from existing director remuneration. The options will grant directors 100 common shares per right, exercisable from two years after issuance and up to 10 years.
Shares of the company were down nearly 12% in recent trade.
Price (JPY): $707.00, Change: $-91, Percent Change: -11.40%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.